D816V mutation in the KIT gene activation loop has greater cell-proliferative and anti-apoptotic ability than N822K mutation in core-binding factor acute myeloid leukemia-Reference-Cited by-同舟云学术

D816V mutation in the KIT gene activation loop has greater cell-proliferative and anti-apoptotic ability than N822K mutation in core-binding factor acute myeloid leukemia

Published:2017-08 Issue: Volume:52 Page:56-64.e4
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Omori Ikuko,Yamaguchi Hiroki,Miyake Koichi,Miyake Noriko,Kitano Tomoaki,Inokuchi Koiti

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference21 articles.

1. Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia;Goemans;Leukemia,2005

2. AML1-ETO9a is correlated with C-KIT overexpression/mutations and indicates poor disease outcome in t(8;21) acute myeloid leukemia-M2;Jiao;Leukemia,2009

3. AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: Implication in stepwise leukemogenesis and response to Gleevec;Wang;Proc Natl Acad Sci U S A,2005

4. Prognostic impact of c-KIT mutations in core binding factor leukemias: An Italian retrospective study;Cairoli;Blood,2006

5. Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): A Cancer and Leukemia Group B Study;Paschka;J Clin Oncol,2006

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KIT mutations and expression: current knowledge and new insights for overcoming IM resistance in GIST;Cell Communication and Signaling;2024-02-27

2. KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX1::RUNX1T1;Pediatric Blood & Cancer;2023-11-28

3. Clinical impact of c-KIT and CEBPA mutations in 33 patients with corebinding factor (Non-M3) acute myeloid leukemia;Pediatrics & Neonatology;2023-07

4. c-Kit signaling potentiates CAR T cell efficacy in solid tumors by CD28- and IL-2-independent co-stimulation;Nature Cancer;2023-06-19

5. Significance of Gene Diagnosis in Acute Myeloid Leukemia with the Emergence of New Molecular Target Drug Treatment;Journal of Nippon Medical School;2022-10-25